Fundraising Fox
/Companies
Sign in

Seal Rock Therapeutics

Seattle, US · Delaware corporation · 1 known investors

Find your way into Seal Rock Therapeutics

Sign up to see every warm intro you have to Seal Rock Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Seal Rock Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Sealrock is a drug development company whose team has worked on the discovery, development, and commercialization of FDA-approved drugs. It focuses on pharmaceutical research and translational medicine.

BiotechHealthtech

Founders & leadership

KEKathleen Elias
Kathleen EliasVP of Research & Translational Medicine / Co-Founder
NMNeil McDonnell
Neil McDonnellChief Executive Officer / Co-Founder
KW
Keith WycoffNamed on SEC filing
APArtur Plonowski
Artur PlonowskiChief Scientific Officer / Co-Founder

Investors · 1

Reported raises · per SEC filings

Form D private placements

$2.5M disclosed across 1 round · 2022

▶$2.5MraisedFeb 2022 · 16 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Neil McDonnellExecutive Officer, Director, Promoter
  • Keith WycoffDirector
  • Artur PlonowskiExecutive Officer, Director, Promoter
Offering amount
$6M
Amount sold
$2.5M
First sale
Jan 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 3

Scholar RockScholar Rock is a biopharmaceutical company that develops therapies targeting growth factor proteins to treat serious diseases. The company uses a selective protein targeting approach designed to inhibit disease mechanisms rather than manage their downstream effects.
AllRock BioAllRock Bio is a drug development company advancing novel therapies for pulmonary hypertension, interstitial lung diseases, and other fibrotic conditions. Its lead program is an orally administered pan-ROCK inhibitor being investigated in pulmonary arterial hypertension and pulmonary hypertension with interstitial lung disease.
DoximityDoximity is the largest verified network of healthcare professionals in the U.S., connecting physicians, PAs, NPs, pharmacists, and medical students across specialties and care settings. The platform provides mobile-first tools for clinical communication, collaboration, and workflow optimization.

Companies working in the same space as Seal Rock Therapeutics.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2022$358.2K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Seal Rock Therapeutics do?
Sealrock is a drug development company whose team has worked on the discovery, development, and commercialization of FDA-approved drugs. It focuses on pharmaceutical research and translational medicine.
Who founded Seal Rock Therapeutics?
Seal Rock Therapeutics was founded by Kathleen Elias.
Who are Seal Rock Therapeutics's investors?
Seal Rock Therapeutics's investors include Elma Ventures.
How much funding has Seal Rock Therapeutics raised?
Seal Rock Therapeutics has disclosed $2.5M raised across 1 round.
Where is Seal Rock Therapeutics headquartered?
Seal Rock Therapeutics is headquartered in Seattle, US.